- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06106061
Effectiveness and Safety of the Facet Fixation (FFX®) Implant in the Treatment of Degenerative Lumbar Spinal Stenosis (FFX® RCT)
This is a prospective, multicentric, comparative, randomised-controlled study to evaluate the safety and efficacy of the Facet Fixation implant.
The main objective is to evaluate the effectiveness of spinal decompression associated with FFX® implants compared to spinal decompression alone in treating lumbar spinal stenosis after 2 years of treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥ 50 years.
- Radiographic confirmation of clinical symptoms of at least moderate degenerative spinal stenosis, of 1 to 3 adjacent segments in the L1-S1 region with the need for surgical decompression.
- Radiographic confirmation of no translational instability in main segment as well as in adjacent segments (dynamic translational instability ≤3 mm);
- Visual analogue scale (VAS) back pain score ≥ 50 mm (on a 100-mm scale).
- Minimum of 3 months of conservative therapy without improvement of symptoms.
- Mental & physical ability of the subject to follow the protocol (i.e., compliance with time schedule & treatment plan, able to fill in questionnaire & to undergo further study procedures).
- Personally signed and dated informed consent document prior to any study-related procedures indicating that the subject has been informed of all pertinent aspects of the clinical investigation.
Exclusion Criteria:
- Prior lumbar spine surgery.
- Radiographically confirmed damage of a vertebral body (e.g., osteoporotic compression fracture or because of tumours), at any lumbar level.
- Isthmic or degenerative spondylolisthesis (anterolisthesis; retrolisthesis ≥ grade II) or spondylolysis (pars fracture).
- Degenerative lumbar scoliosis (Cobb angle > 25°).
- Adipositas (obesity); defined as a body mass index (BMI) >40.
- Pregnancy, or wish to get pregnant during the course of the study, or breastfeeding.
- Known allergy or sensitivity to titanium, titanium alloys, or MRI contrast agents.
- Active or chronic infection-systemic or local.
- History of significant peripheral neuropathy.
- Significant peripheral vascular disease (e.g., with diminished dorsalis pedis or posterior tibial pulses).
- Paget disease, osteomalacia or other metabolic bone disorders.
- Cauda equina syndrome.
- Known or documented history of transmissible disease, including AIDS, HIV and active hepatitis.
- More than 3 vertebral levels requiring surgery.
- Disc herniation at any lumbar level requiring surgical intervention.
- Known osteoporosis (bone mineral density, BMD < 120 mg/cm3).
- Chronically taking medications or any drug known to potentially interfere with bone/soft tissue healing (e.g., steroids), not including a Medrol (methylprednisolone) dose pack.
- Fixed and complete motor, sensory, or reflex deficit.
- Rheumatoid arthritis or other autoimmune diseases.
- Active malignancy: a subject with a history of any invasive malignancy (except non-melanoma skin cancer) unless he/she has been treated with curative intent and there has been no clinical signs or symptoms of the malignancy for at least 5 years. Subjects with a primary bony tumour are excluded as well.
- Subject with a history of substance abuse (e.g., recreational drugs, narcotics, or alcohol).
- Bone destruction, demineralisation or any affection potentially affecting fixation of an implant.
- Spondylodiscitis or spine tumour.
- Currently seeking or receiving workman's compensation.
- In active spinal litigation.
- Subjects who participate(d) in another clinical trial (within the last 4 weeks) that might influence the safety & effectiveness assessment of this trial.
- Subjects who are lawfully kept in an institution.
- Subject who, in the opinion of the investigator, will be inappropriate for inclusion in this clinical trial or who will not comply with requirements of the study.
- Subject under supervision or legal guardianship, or judicial protection.
- Subject deprived of liberty by judicial or administrative decision.
- Subject not covered by a social security scheme.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group one: Decompression + FFX®
|
Surgical treatment of degenerative lumbar spinal stenosis by spinal decompression associated with the use of FFX® implant
|
Active Comparator: Group two: Decompression alone
|
Surgical treatment of degenerative lumbar spinal stenosis by spinal decompression alone
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of subjects with composite clinical success (CCS)
Time Frame: 2 years
|
The CCS will be considered as met if ALL of the following criteria are satisfied for a subject:
|
2 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-A01382-43
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Degenerative Lumbar Spinal Stenosis
-
Azienda Usl di BolognaRecruitingLumbar Spinal Stenosis | Degenerative Lumbar Spinal StenosisItaly
-
Peking University Third HospitalRecruitingDegenerative Scoliosis | Degenerative Lumbar Spinal StenosisChina
-
Ohio State UniversityNexxt Spine, LLCCompletedLumbar Spinal Stenosis | Lumbar Spondylolisthesis | Lumbar Degenerative Disc Disease | Lumbar Spondylosis | Lumbar Spinal DeformityUnited States
-
Seoul National University HospitalCompletedDegenerative Lumbar Spinal StenosisKorea, Republic of
-
Taipei Veterans General Hospital, TaiwanCompletedDegenerative Lumbar Spinal Stenosis | Lumbarsacral Orthosis | Transforaminal Lumbar Interbody FusionTaiwan
-
BioAlpha Inc.CompletedDegenerative Lumbar Spinal Stenosis
-
National Taiwan University HospitalRecruitingDegenerative Disc Disease | Degenerative Spondylolisthesis | Degenerative Intervertebral Discs | Degenerative Lumbar Spinal StenosisTaiwan
-
Seoul National University HospitalCompletedDegenerative Lumbar Spinal StenosisKorea, Republic of
-
Haukeland University HospitalMøre og Romsdal Hospital TrustActive, not recruitingDegenerative Spondylolisthesis | Degenerative Lumbar Spinal StenosisNorway
-
Spine Centre of Southern DenmarkCompletedDegenerative Spondylolisthesis | Degenerative Lumbar Spinal StenosisDenmark
Clinical Trials on Decompression + FFX®
-
Napa Pain InstituteVertos Medical, Inc.CompletedLumbar Spine Stenosis Central CanalUnited States
-
Vertos Medical, Inc.CompletedLumbar Spinal StenosisUnited States
-
Boston Scientific CorporationCompletedLumbar Spinal StenosisUnited States
-
Baxano Surgical, Inc.UnknownRadiculopathy | Lumbar Spinal Stenosis | SpondylolisthesisUnited States
-
Xtant MedicalMCRARecruiting
-
VertiFlex, IncorporatedWithdrawnSpinal Stenosis, Lumbar Region With Neurogenic ClaudicationUnited States
-
Erasme University HospitalUniversity of Liege; Bone Therapeutics S.ACompletedAvascular Necrosis of Femur HeadBelgium
-
Medtronic Spine LLCCompletedLumbar Spinal StenosisUnited States
-
Vertos Medical, Inc.CompletedLumbar Spinal StenosisUnited States
-
Coastal Orthopedics & Sports MedicineVertos Medical, Inc.Completed